Jana Jaal

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon

Darja Lavõgina, Helen Lust, Maris‐Johanna Tahk et al. · Biosensors · 2022 · 109 citations · Full text

Cellular Viability, Engineering, Biomedical Engineering +23

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase <scp>II</scp> trial

Davey B. Daniel, Vladimer Kuchava, Igor Bondarenko et al. · International Journal of Cancer · 2020 · 78 citations · Full text

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey

Peter Dunscombe, Cai Grau, Noémie Defourny et al. · Radiotherapy and Oncology · 2014 · 76 citations · Full text

Recommended ESTRO Core Curriculum for Radiation Oncology/Radiotherapy 4th edition

Kim Benstead, Pedro C. Lara, Demetrius Andreopoulos et al. · Radiotherapy and Oncology · 2019 · 53 citations

Radiation Medicine, Medicine, Radiologic Education +5